White Janson, Beck Christine R, Harel Tamar, Posey Jennifer E, Jhangiani Shalini N, Tang Sha, Farwell Kelly D, Powis Zöe, Mendelsohn Nancy J, Baker Janice A, Pollack Lynda, Mason Kati J, Wierenga Klaas J, Arrington Daniel K, Hall Melissa, Psychogios Apostolos, Fairbrother Laura, Walkiewicz Magdalena, Person Richard E, Niu Zhiyv, Zhang Jing, Rosenfeld Jill A, Muzny Donna M, Eng Christine, Beaudet Arthur L, Lupski James R, Boerwinkle Eric, Gibbs Richard A, Yang Yaping, Xia Fan, Sutton V Reid
Department of Molecular and Human Genetics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, 77030, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Genome Med. 2016 Jan 6;8(1):3. doi: 10.1186/s13073-015-0253-0.
Large-scale cohort-based whole exome sequencing of individuals with neurodevelopmental disorders (NDDs) has identified numerous novel candidate disease genes; however, detailed phenotypic information is often lacking in such studies. De novo mutations in pogo transposable element with zinc finger domain (POGZ) have been identified in six independent and diverse cohorts of individuals with NDDs ranging from autism spectrum disorder to developmental delay.
Whole exome sequencing was performed on five unrelated individuals. Sanger sequencing was used to validate variants and segregate mutations with the phenotype in available family members.
We identified heterozygous truncating mutations in POGZ in five unrelated individuals, which were confirmed to be de novo or not present in available parental samples. Careful review of the phenotypes revealed shared features that included developmental delay, intellectual disability, hypotonia, behavioral abnormalities, and similar facial characteristics. Variable features included short stature, microcephaly, strabismus and hearing loss.
While POGZ has been associated with neurodevelopmental disorders in large cohort studies, our data suggest that loss of function variants in POGZ lead to an identifiable syndrome of NDD with specific phenotypic traits. This study exemplifies the era of human reverse clinical genomics ushered in by large disease-directed cohort studies; first defining a new syndrome molecularly and, only subsequently, phenotypically.
对患有神经发育障碍(NDDs)的个体进行基于大规模队列的全外显子组测序已鉴定出众多新的候选疾病基因;然而,此类研究往往缺乏详细的表型信息。在六个独立且多样的NDDs个体队列中已鉴定出锌指结构域的pogo转座元件(POGZ)中的新生突变,这些个体涵盖从自闭症谱系障碍到发育迟缓等多种情况。
对五名无亲缘关系的个体进行全外显子组测序。使用桑格测序法验证变异,并在现有家庭成员中将突变与表型进行分离。
我们在五名无亲缘关系的个体中鉴定出POGZ中的杂合截短突变,这些突变在现有亲本样本中被确认为新生突变或不存在。对表型的仔细审查揭示了共同特征,包括发育迟缓、智力残疾、肌张力减退、行为异常和相似的面部特征。可变特征包括身材矮小、小头畸形、斜视和听力损失。
虽然在大型队列研究中POGZ已与神经发育障碍相关联,但我们的数据表明POGZ中的功能丧失变异导致具有特定表型特征的可识别的NDD综合征。这项研究例证了由大型疾病导向队列研究开创的人类反向临床基因组学时代;首先在分子水平上定义一种新综合征,随后才在表型水平上进行定义。